NMPA Approval

Fluoxetine Hydrochloride Dispersible Tablets

Approval Number

国药准字H20233241

Company恒昌（广州）新药研究有限公司

Registration Date

February 28, 2023

Drug Information

Generic Name

盐酸氟西汀分散片

Dosage Form

片剂

Strength

20mg（按C₁₇H₁₈F₃NO计）

Drug Type

化学药品

Registration Date

February 28, 2023

Company Information

Applicant Company

Company Name恒昌（广州）新药研究有限公司

Company Address

广州市黄埔区神舟路288号C栋1001房

Manufacturing Company

Company Name江西施美药业股份有限公司

Company Address

江西省抚州市东乡区大富工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸氟西汀分散片 - NMPA 批准文号 | MedPath